NCT05250245

Tolterodine Relieves Overactive Bladder Symptoms in Women With Moderate-to-severe Obstructive Sleep Apnea Syndrome

Effect of Combined Use of Tolterodine and Continuous Positive Airway Pressure vs Continuous Positive Airway Pressure Only Treatment on Overactive Bladder Symptoms in Women With Moderate-to-severe Obstructive Sleep Apnea Syndrome: A Randomized Clinical Trial

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 60 (actual)
• Sponsor: Yuzuncu Yil University · Academic / Other
• Sex: Female
• Age: 18 Years – 60 Years
• Healthy volunteers: Not accepted

Summary

In this study, we aim to determine whether combined tolterodine and CPAP therapy is a more effective treatment for patients with OSAS than CPAP treatment only.

Conditions

• Overactive Bladder
• Obstructive Sleep Apnea
• Overactive Bladder Syndrome

Interventions

Type	Name	Description
DRUG	Tolterodine Tartrate 4 MG	Tolterodine is actively being used in the treatment of over active bladder symptoms today
OTHER	Continuous positive airway pressure therapy (CPAP)	The gold standard for the treatment of confirmed OSAS is continuous positive airway pressure (CPAP) therapy

Timeline

• Start date: 2020-06-01
• Primary completion: 2021-12-30
• Completion: 2022-01-01
• First posted: 2022-02-22
• Last updated: 2022-02-22

Locations

1 site across 1 country: Turkey (Türkiye)